Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease
出版年份 2020 全文链接
标题
Development and validation of a novel non‐invasive test for diagnosing fibrotic non‐alcoholic steatohepatitis in patients with biopsy‐proven non‐alcoholic fatty liver disease
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-04-05
DOI
10.1111/jgh.15055
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
- (2019) Jiang-Hua Zhou et al. WORLD JOURNAL OF GASTROENTEROLOGY
- MACK‐3 (combination of hoMa, Ast and CK18): A promising novel biomarker for fibrotic non‐alcoholic steatohepatitis
- (2019) Kee‐Huat Chuah et al. LIVER INTERNATIONAL
- New sequential combinations of noninvasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD
- (2019) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Individualized risk prediction of significant fibrosis in non-alcoholic fatty liver disease using a novel nomogram
- (2019) Yu-Jie Zhou et al. United European Gastroenterology Journal
- Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis
- (2019) Donghee Kim et al. JOURNAL OF GASTROENTEROLOGY
- PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels
- (2019) Dan‐Qin Sun et al. LIVER INTERNATIONAL
- Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease
- (2019) Wen‐Yue Liu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Screening for therapeutic trials and treatment indication in clinical practice: MACK-3, a new blood test for the diagnosis of fibrotic NASH
- (2018) J. Boursier et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- Diagnostic Accuracy of Platelet Count and Platelet Indices in Noninvasive Assessment of Fibrosis in Nonalcoholic Fatty Liver Disease Patients
- (2017) Tamara Milovanovic Alempijevic et al. Canadian Journal of Gastroenterology and Hepatology
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Nonalcoholic fatty liver disease
- (2015) Elizabeth M. Brunt et al. Nature Reviews Disease Primers
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Liver biopsy
- (2008) Don C. Rockey et al. HEPATOLOGY
- Non-invasive evaluation of liver fibrosis using transient elastography
- (2008) Laurent Castera et al. JOURNAL OF HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started